Sterling Investment Advisors Ltd. Acquires 1,700 Shares of Astera Labs, Inc. $ALAB

Sterling Investment Advisors Ltd. raised its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 84.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,725 shares of the company’s stock after buying an additional 1,700 shares during the quarter. Sterling Investment Advisors Ltd.’s holdings in Astera Labs were worth $408,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Reflection Asset Management bought a new position in shares of Astera Labs in the fourth quarter worth approximately $25,000. Smartleaf Asset Management LLC grew its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank increased its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in shares of Astera Labs in the 4th quarter worth $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs during the 4th quarter valued at $33,000. 60.47% of the stock is currently owned by institutional investors.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 8,491 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the sale, the director owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. This represents a 2.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,037,724 shares of company stock valued at $507,157,341. Insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ALAB shares. UBS Group lifted their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a report on Monday, June 29th. Roth Capital restated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Bank of America lifted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Needham & Company LLC upped their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $275.75.

Astera Labs Trading Down 0.1%

Shares of NASDAQ:ALAB opened at $361.78 on Wednesday. The stock’s 50-day moving average price is $342.03 and its 200-day moving average price is $217.65. Astera Labs, Inc. has a 12-month low of $88.73 and a 12-month high of $499.48. The stock has a market capitalization of $62.01 billion, a P/E ratio of 244.45, a price-to-earnings-growth ratio of 4.07 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the prior year, the business posted $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 1.88 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.